
Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions

Mytos builds robots that grow human cells. Our machines take stem cells as input, and grow them into specific cells like neurons or heart cells. Customers use our platform to scale stem-cell derived therapies to more patients sooner. We're also used to produce cells for testing new drugs on during R&D in Drug Discovery. Mytos is backed by leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists. We're hiring now - visit our website to see open positions
What they do: Build automated robots (iDEM) to grow stem-cell derived human cells and operate an automated CDMO for regenerative-medicine production
HQ: London, United Kingdom
Founders: Ali Afshar and Ignacio Willats
Funding: Company states >$24M raised; reports reference a ~$19M Series A
Employee count: 48
Scaling manufacturing of stem-cell derived therapies and producing consistent, high-throughput human cells for therapeutic and drug-discovery use cases.
Biotechnology Research
$19.0M
Reported by dealroom and company newsroom
“Includes investors such as Wing Venture Capital, IQ Capital, and Buckley Ventures; additional angels and founders/executives from technology and biotech companies are listed as backers”
| Company |
|---|
About Us You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you’ll help scale cures to patients that need them sooner.
We’ve developed fully-automated cell manufacturing sites powered by custom robotics - to scale therapies to millions of patients. Last year, patients were cured of diseases like Parkinson’s and vision loss using stem-cell derived cells - but today these Regenerative Medicines are produced by hand, meaning they’re too expensive and hard to scale. With our automated CDMO, these therapies can now be scaled globally at low cost.
We've announced partnerships across multiple therapies so far ranging from Parkinson’s, to hearing loss, to bone repair - and raised $24m to expand into the market faster, and accelerate our development! Within the next 12-18 months, neurons grown on our machines will be going into Parkinson’s patient brains.
We’ve assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. You can learn more about your potential Mytos teammates here: Team
Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.
THE ROLE
We are looking for a high-growth stem cell scientist to join our biology team and push the limits of automation in cell therapy manufacture. This is a unique opportunity to learn how to execute projects at the interface of engineering and biology.
We believe in autonomy, and you should expect to run your own projects and attempt to overcome hurdles you encounter, with team members always available to advise as you require.
You will be interfacing with multiple disciplines across biology, hardware and software, so expect to have the opportunity to learn about these different disciplines as part of the role.
Core Responsibilities
Required Skills & Experience
Desired Qualities
Benefits
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.